B
Bioventix
Organization
A UK biotechnology company that develops and commercializes high-affinity antibodies used in diagnostic tests, particularly in clinical laboratories.
What experts have said about Bioventix
3 statements · 1 positive · 2 negative
Bioventix’s share price has fallen sharply and persistently.
“I think most— Bioventix is another one that used to be such a quality growth stock, but the share price is just a 45-degree line downwards.”
Open the episode · Paul's Podcast - Fri 13 Mar 2026Listen at 32:53
Bioventix’s 10.5% yield signals doubts about dividend sustainability.
“10.5% dividend yield, which is saying to you the market doesn't think the dividends are sustainable.”
Open the episode · Paul's Podcast - Fri 13 Mar 2026Listen at 33:09
Bioventix may be entering speculative buying territory.
“it's got to be coming into having a punt range, hasn't it really, Bioventix?”
Open the episode · Paul's Podcast - Fri 13 Mar 2026Listen at 33:27
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
